Literature DB >> 9885020

Exomphalos (omphalocele)

M D Kilby1, A Lander, M Usher-Somers.   

Abstract

Exomphalos affects approximately 3 in 10,000 births and can arise from a number of developmental insults. The clinical outcome is dependent upon the associated structural and chromosomal anomalies and the gestation at delivery. Accurate antenatal ultrasound diagnosis and karyotyping are important and allow informed prenatal and postnatal management decisions to be made. Prenatal care and counselling should be multidisciplinary and information should ideally be given to parents regarding prognosis and outcome based on prospectively collected population-based data.

Entities:  

Mesh:

Year:  1998        PMID: 9885020     DOI: 10.1002/(sici)1097-0223(199812)18:12<1283::aid-pd480>3.0.co;2-4

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

Review 1.  Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature.

Authors:  Polina Frolov; Jasem Alali; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2010-08-31       Impact factor: 1.827

2.  Gastroschisis and omphalocele: treatments and long-term outcomes.

Authors:  Katharina Henrich; Hans P Huemmer; Bertram Reingruber; Peter G Weber
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

3.  Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling.

Authors:  Elisabeth Sock; Stefanie D Rettig; Janna Enderich; Michael R Bösl; Ernst R Tamm; Michael Wegner
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

4.  Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin.

Authors:  R Doyonnas; D B Kershaw; C Duhme; H Merkens; S Chelliah; T Graf; K M McNagny
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.